T-Cell immunotherapy for B-lineage acute lymphoblastic leukemia using chimeric antigen receptors that deliver 4-1BB-mediated costimulatory signals.

被引:0
|
作者
Imai, C
Mihara, K
Andreansky, M
Geiger, TL
Campana, D
机构
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Univ Tennessee, Ctr Hlth Sci, Memphis, TN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
223
引用
收藏
页码:66A / 67A
页数:2
相关论文
共 50 条
  • [1] Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
    Maino, Elena
    Scattolin, Anna Maria
    Viero, Piera
    Sancetta, Rosaria
    Pascarella, Anna
    Vespignani, Michele
    Bassan, Renato
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
  • [2] Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
    Aldoss, I.
    Bargou, R. C.
    Nagorsen, D.
    Friberg, G. R.
    Baeuerle, P. A.
    Forman, S. J.
    LEUKEMIA, 2017, 31 (04) : 777 - 787
  • [3] Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
    I Aldoss
    R C Bargou
    D Nagorsen
    G R Friberg
    P A Baeuerle
    S J Forman
    Leukemia, 2017, 31 : 777 - 787
  • [4] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [5] The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
    Gerard J. Chu
    Charles G. Bailey
    Rajini Nagarajah
    Sharon M. Sagnella
    Stephen Adelstein
    John E. J. Rasko
    Cancer Cell International, 23
  • [6] The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+T-cell functionality following T-cell receptor stimulation
    Chu, Gerard J.
    Bailey, Charles G.
    Nagarajah, Rajini
    Sagnella, Sharon M.
    Adelstein, Stephen
    Rasko, John E. J.
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [7] CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
    Chen, Runzhe
    Song, Xiao-Tong
    Chen, Baoan
    DISCOVERY MEDICINE, 2015, 20 (110) : 185 - 190
  • [8] Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
    Beyar-Katz, Ofrat
    Rowe, Jacob M.
    HAEMATOLOGICA, 2024, 109 (06) : 1631 - 1633
  • [9] T-CELL RECEPTOR BETA-CHAIN GENE-EXPRESSION IN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    TAWA, A
    KAWAHA, K
    ISHIHARA, S
    YUMURAYAGI, K
    TERADA, N
    MURATA, M
    IZUMI, Y
    YABUUCHI, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (03): : 359 - 364
  • [10] Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Current Landscape in 2021
    Gauthier, Jordan
    Turtle, Cameron J.
    CANCER JOURNAL, 2021, 27 (02): : 98 - 106